
Pulled from Benzinga Pro data, PLx Pharma (NASDAQ:PLXP) posted Q4 earnings of $3.56 million, an increase from Q3 of 116.46%. Sales dropped to $1.59 million, a 75.94% decrease between quarters. In Q3, PLx Pharma brought in $6.62 million in sales but lost $21.64 million in earnings.